Pfizer Inc (PFE)

PFE on New York Consolidated

31.25USD
30 Jan 2015
Change (% chg)

$-0.58 (-1.82%)
Prev Close
$31.83
Open
$31.67
Day's High
$31.80
Day's Low
$31.20
Volume
43,070,750
Avg. Vol
25,221,968
52-wk High
$33.50
52-wk Low
$27.51

PFE

Chart for PFE

About

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company’s diversified global healthcare portfolio includes human... (more)

Overall

Beta: 0.71
Market Cap(Mil.): $196,895.50
Shares Outstanding(Mil.): 6,300.66
Dividend: 0.28
Yield (%): 3.58

Financials

  PFE Industry Sector
P/E (TTM): 22.05 37.76 38.54
EPS (TTM): 1.42 -- --
ROI: -- 18.79 18.06
ROE: -- 19.44 18.83
Search Stocks

Pfizer to pay $400 million to avert investor class action trial

NEW YORK - Pfizer Inc said on Tuesday it agreed to pay $400 million to avert a trial in a class action lawsuit accusing the pharmaceutical giant of misleading investors in connection with off-label marketing.

27 Jan 2015

Pfizer's 2015 forecast disappoints, crimped by generics, dollar

- Pfizer Inc reported stronger-than-expected quarterly sales due to cost cuts and demand for its vaccines and cancer drugs, but the company forecast 2015 earnings below Wall Street expectations, citing patent expirations and the stronger dollar.

27 Jan 2015

Pfizer to pay $400 million to avert investor class action trial

NEW YORK - Pfizer Inc said on Tuesday it agreed to pay $400 million to avert a trial in a class action lawsuit accusing the pharmaceutical giant of misleading investors in connection with off-label marketing.

27 Jan 2015

Pfizer to pay $400 million to avert investor class action trial

NEW YORK, Jan 27 - Pfizer Inc said on Tuesday it agreed to pay $400 million to avert a trial in a class action lawsuit accusing the pharmaceutical giant of misleading investors in connection with off-label marketing.

27 Jan 2015

BRIEF-Pfizer CEO says company doesn't need to do a big deal

Jan 27 - Pfizer Inc : * CEO says company doesn't need to do a big deal, would consider worthwhile

27 Jan 2015

UPDATE 1-Pfizer's 2015 forecast disappoints, crimped by generics, dollar

Jan 27 - Pfizer Inc reported stronger-than-expected quarterly sales due to cost cuts and demand for its vaccines and cancer drugs, but the company forecast 2015 earnings below Wall Street expectations, citing patent expirations and the stronger dollar.

27 Jan 2015

US STOCKS-Futures fall with Microsoft, Greek worries linger

NEW YORK, Jan 27 - U.S. stock index futures fell on Tuesday, weighed by company earnings results including those of Microsoft, while concerns lingered over Greece's new anti-bailout government and its implications for the euro zone.

27 Jan 2015

Pfizer's 2015 forecast disappoints, crimped by generics, dollar

Jan 27 - Pfizer Inc reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased, but the company forecast 2015 earnings below Wall Street expectations, citing patent expirations and the stronger dollar.

27 Jan 2015

Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 billion

LONDON - Pfizer is to cut the price of its pneumococcal vaccine Prevenar 13 by 6 percent to $3.10 per dose in poor countries as part of a commitment to the GAVI global vaccines alliance, the U.S. drugmaker said on Monday.

26 Jan 2015

Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bln

LONDON, Jan 26 - Pfizer is to cut the price of its pneumococcal vaccine Prevenar 13 by 6 percent to $3.10 per dose in poor countries as part of a commitment to the GAVI global vaccines alliance, the U.S. drugmaker said on Monday.

26 Jan 2015

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $100.14 -2.24
Novartis AG (NOVN.VX) CHF90.15 -0.85
Merck & Co., Inc. (MRK.N) $60.28 -1.81
Roche Holding Ltd. (ROG.VX) CHF248.60 -4.10
Abbott Laboratories (ABT.N) $44.76 -0.50
Bayer AG (BAYGn.DE) €128.05 -0.70
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €82.00 -0.26
AstraZeneca plc (AZN.L) 4,743.00p -18.50
GlaxoSmithKline plc (GSK.L) 1,467.00p -25.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks